The following papers and articles are known about Degos Disease. Please let us know of any other papers by contacting us.
You can also search PubMed, from the United States National Library of Medicine.
Diffuse atrophic papules and plaques, intermittent abdominal pain, paresthesias, and cardiac abnormalities in a 55-year-old woman
Reference: Journal of the American Academy of Dermatology, Volume 75, Issue 6, 2016 Dec
Degos disease mimicking primary vasculitis of the CNS
Reference: Neurol Neuroimmunol Neuroinflamm April 2016 vol. 3 no. 2 e206
Correspondence: <Correspondence to Dr. Gmuca: email@example.com>
Bowel perforation in Dego’s disease: a lethal surgical scenario
Reference: Int Surg J. 2016; 3(1): 361-363doi: 10.18203/2349-2902.isj20151489
Aspirin in dermatology: Revisited
Department of Dermatology, Sri Ramachandra University, Chennai, Tamil Nadu, India
Reference: Indian Dermatol Online J [serial online] 2015 [cited 2015 Nov 24];6:428-35.
Acquired neurocutaneous disorders.
1Department of Neurology, Hartford Hospital – University of Connecticut, Hartford CT, USA. 2Section of Dermatopathology, Department of Pathology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. 3Department of Neurology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA. Electronic address: firstname.lastname@example.org.
Reference: Handb Clin Neurol. 2015;132:29-73. doi: 10.1016/B978-0-444-62702-5.00003-2.
Title: Anti-C5 antibodies having improved pharmacokinetics Document Type and Number: United States Patent 9079949
Title: COMPOSITIONS COMPRISING A COMPLEMENT INHIBITOR AND AN INTERFERON ALPHA INHIBITOR Document Type and Number: United States Patent Application 20150174243 Kind Code: A1
Title: Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation Document Type and Number: United States Patent Application 20150166675 Kind Code: A1
Reference: Application Number: 14/517750 International Classes: C07K16/40; A61K39/395
Malign atrofik papüloz (Köhlmeier-Degos hastalığı)
Degos disease – malignant atrophic papulosis or cutaneointestinal lethal syndrome: rarity of the disease
Spaulding Rehabilitation Network Research Laboratory, Harvard Medical School, Boston, MA, USA; 2University of São Paulo, Sirio Libanes Hospital, São Paulo, Brazil; Sirio Libanes Hospital, São Paulo, Brazil
Reference: Journal of Clinical and Experimental Gastroenterology, April 2015 Volume 2015:8 Pages 141—147
Title: Methods for treating multiorgan, systemic degos’ disease with a complement inhibitor Document Type and Number: United States Patent 8999340
Degos Disease Associated with Behçet’s Disease
Department of Dermatology, Chonnam National University Medical School, Gwangju, Korea.
Reference: Ann Dermatol. 2015 Apr;27(2):235-236. English.
Degos disease: report of a case and review of the literature.
Dermatology Section, Department of Clinical Medicine and Immunological Sciences, University of Siena, Siena, Italy – .
Reference: G Ital Dermatol Venereol. 2015 Feb;150(1):123-129.
Skin in Rheumatic Disease
Reference: Clinical Basis of Rheumatic Disease
Challenging Mimickers of Primary Systemic Vasculitis.
1Rheumatology Unit, Massachusetts General Hospital, Yawkey 2, 55 Fruit Street, Boston, MA 02114, USA.
Reference: Rheum Dis Clin North Am. 2015;41(1):141-160. doi: 10.1016/j.rdc.2014.09.011
Non-atherosclerotic Causes of Mesenteric Arterial Disease
4. Division of Vascular and Endovascular Surgery, Mayo Clinic, Rochester, MN, USA
Reference: Mesenteric Vascular Disease 2015, pp 123-144
Renal involvement in Malignant Atrophic Papulosis (Degos Disease)
Nephrology-Dialysis Department, Civico and Di Cristina Hospital – Palermo, Italy.
Reference: An Bras Dermatol. 2015 Mar-Apr; 90(2): 285.
Malignant Atrophic Papulosis Is Challenging to Diagnose, Treat
Steffens Scleroderma Center in Albany and Saratoga Springs, N.Y and Albany College of Pharmacy and Health Sciences in Albany, N.Y
Reference: The Rheumatologist – An official publication of the ACR and the ARHP serving rheumatologists and rheumatology health professionals
Degos Disease A C5b-9/Interferon-α–Mediated Endotheliopathy Syndrome
Division of Dermatopathology, Department of Pathology and Laboratory Medicine, Weill Cornell College of Cornell University, New York, NY; Department of Immunology, Duke University Medical Center, Durham, NC; New York University, New York; Department of Rheumatology, Albany Medical College, Albany, NY; Pathology, Ohio State University, Columbus; Division of Rheumatology, Hospital for Special Surgery, New York, NY; and Genetic Medicine, University of Manchester, Manchester Academic Health Science Centre, Central Manchester Foundation Trust University Hospitals, Manchester, England
Reference: American Society for Clinical Pathology
Case 18-2014 — A 32-Year-Old Man with a Rash, Myalgia, and Weakness
The Massachusetts General Hospital, Boston
Reference: N Engl J Med 2014; 370:2327-2337June 12, 2014DOI: 10.1056/NEJMcpc1304161
Severe Neurologic Involvement of Degos Disease in a Pediatric Patient
Reference: J Child Neurol April 2014 vol. 29 no. 4 550-554
Degos Disease: an update
Malignant and benign forms of atrophic papulosis (Köhlmeier-Degos disease): systemic involvement determines the prognosis.
Reference: Br J Dermatol. 2014 Jan;170(1):110-5. doi: 10.1111/bjd.12642.
Degos Hastalığı (Malign Atrofik Papülozis)
Romatoloji BD, İstanbul Üniversitesi İstanbul Tıp Fakültesi, İstanbul
Reference: Turkiye Klinikleri J Rheumatol-Special Topics 2014;7(1):33-7 Makale Dili: TR Ücretsiz Erişim
The effects of Eculizumab on the pathology of malignant atrophic papulosis
Cynthia M Magro,1 Xuan Wang,1 Francine Garrett-Bakelman,2 Jeffrey Laurence,2 Lee S Shapiro,3 and Maria T DeSancho2 1Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, Box 58, Room F-309, 1300 York Avenue, New York, New York 10065, USA 2Division of Hematology/Medical Oncology, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10065, USA 3The Center for Rheumatology, LLP, 1367 Washington Ave., Suite 101, Albany, NY 12206, USA
Malignant atrophic papulosis (Köhlmeier-Degos disease) – A review
1Departments of Dermatology, Venerology, Allergology and Immunology, Dessau Medical Center, Auenweg 38, Dessau 06847, Germany
Reference: Theodoridis et Al, Orphanet Journal of Rare Diseases 2013 8.10
Effective treatment of malignant atrophic papulosis (Köhlmeier-Degos disease) with treprostinil – early experience
Correspondence: Lee S Shapiro <Leeshapiromd@gmail.com>
Effective Treatment of Degos Disea with Treprostinil-Early Experience (abstract).
2nd Systemic Sclerosis World Congress Madrid, Spain
fatal case of Degos’ disease which presented with recurrent intestinal perforation
Reference: World J Gastrointest Surg. 2011 Oct 27; 3(10): 156–158. Published online 2011 Oct 27. doi: 10.4240/wjgs.v3.i10.156 PMCID: PMC3220729
LETHAL SYSTEMIC DEGOS DISEASE WITH PROMINENT CARDIO-PULMONARY INVOLVEMENT
From the Department of Surgery, Sina Hospital, Tehran, Iran 1Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran 2Department of Pathology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran
Reference: Indian J Dermatol. 2011 Sep-Oct; 56(5): 564–567. doi: 10.4103/0019-5154.87157 PMCID: PMC3221225